Clinical Trial Update: Evaluation of Meningococcal C Vaccine Programmes in Canadian Children [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating meningococcal serogroup C vaccine programmes in Canadian children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease Serogroup

Drugs mentioned

• Meningococcal C vaccine (unspecified)

Snippet

Sponsor: University of British Columbia | Conditions: Meningococcal Sero-type C Infection | Phase 4 | Status: COMPLETED